Ticker
GRCECompany Name
GRACE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -30.87% | $ 44.39M | $ 13.71M |
3/31/2025 | -34.63% | $ 40.52M | $ 14.03M |
12/31/2024 | 0% | $ 35.29M | $ 0 |
9/30/2024 | 0% | $ 30.93M | $ 0 |
6/30/2024 | -30.75% | $ 23.93M | $ 7.36M |
3/31/2024 | -23.72% | $ 31.02M | $ 7.36M |
12/31/2023 | -30% | $ 24.53M | $ 7.36M |
9/30/2023 | -36.41% | $ 20.21M | $ 7.36M |
6/30/2023 | -0.6% | $ 18.02M | $ 109K |
3/31/2023 | -1.22% | $ 24.97M | $ 304K |
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for GRACE THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 13.27M ]) / Market Cap [ $ 20.19M ]
(=) Buyback Yield [ -65.71% ]
Minimum
Sep 30, 2021
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.43% |
average | 0.64% |
median | 0.01% |
std | 2.7% |